Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @augustoNYC
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @augustoNYC
-
Augusto Villanueva proslijedio/la je Tweet
Chaired by Dr. Amit Singal and Dr. Tim Meyer and with an expected 150 participants this year’s single topic workshop has plentiful opportunities to learn and network!
#ILCA#workshop#networking#livercancerpic.twitter.com/lF2fAIMryk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
Female talent: scientists speak out: What obstacles have you encountered as a female scientist? What advice would you give female researchers who are starting out? Isabel Graupera (
@igraupe) responds#11F#11F2020#womeninscience#womeninsteam#Donaiciència@hospitalclinicpic.twitter.com/NrCQ7doJKLHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
wonderful deep dive on intra-tumour heterogeneity in liver cancer- fascinating interplay of spatio-temporal immune/cancer cell interactions
@augustoNYC@craig_mandy@JohannvonFelden@Teresaglezana@TischCancer@MountSinaiNYC@SinaiGenetics@IcahnInstitutehttps://www.nature.com/articles/s41467-019-14050-z …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
Can we apply this to
#livercancer#hcc? a disease in great need for prevention/interception, ideas you guys have brilliantly advocated for#PDAC. Great opportunity in this space given the ability to access liver with drugs/small RNAs.@docamitgs@DJSiegwart@nicole_rich8@SU2Chttps://twitter.com/Aiims1742/status/1222212578211811329 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
Attend ILCA's new educational activity! The Single-Topic Workshop will delve into the prevention, risk stratification and early detection of HCC-related diseases https://bit.ly/3aIH2rb
#ILCA#workshop#networking#livercancer#singletopicworkshoppic.twitter.com/hXF4ld2KgS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
CDC confirms 3 new cases of novel
#coronavirus (#2019nCoV) infection in the U.S., 1 in AZ & 2 in CA, bringing total to 5. All US cases travelled from Wuhan, China. More cases may be identified. However, risk to US general public is still considered low. https://bit.ly/2Gd1R07 pic.twitter.com/4RVMxJ1Wh0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
Open Access!! The 2019 WHO classification of tumours of the digestive system
#GIpathhttps://onlinelibrary.wiley.com/doi/10.1111/his.13975#.Xis3MgnKDOw.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
Terrific thought exercise by
@augustoNYC about the increasingly small volumetric percentage of tumor sampled by biopsies as mass size increases, potentially missing a vast swath of heterogeneity#GI20pic.twitter.com/LfDKJpcSBs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
.
@augustoNYC explains that ‘one of these things is not like the other’ wherein HCC distinguished itself transcriptomally from nearly all other solid tumors#GI20pic.twitter.com/z1ENRhOsuw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
Atezo/bev vs Sorafenib in advanced HCC, time to deterioration in quality of life favors atezo/bev.
#GI20#PROspic.twitter.com/S2tSIp0MSO
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
Hear about advances in
#HCC therapeutics at HCC-TAG. Great line-up of speakers!
@HccTagConf@laurakulik1@HoshidaYujin@DrElkhoueiry@riadsalemIR@NDP1001@JulieHeimbach@AnjanaPillaiMD@GABOUALFA@hccconnectinfo@BlueFaeryLiver@GlobalLiver@AASLDtweets#livertwitterhttps://twitter.com/onclive/status/1220710406597025794 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
ILCA 2020 website is now live! Submit your abstract and discover the preliminary scientific programme and the topics to be presented during the conference in Madrid this September! https://www.ilca2020.org pic.twitter.com/ZgAEBwC5cy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bruce Lee with Lightsaber Nunchuks! https://youtu.be/O1iCFaXaN-Q via
@YouTubeHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
Por cierto, en TCM empieza “12 hombres sin piedad”. De nada.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
Cada vez falta menos para el
@euroeus2020 Os esperamos a todos en Santiago de Compostela@SEEDendoscopia@ESGE_news@sepdigestivahttp://www.euro-eus.orgHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
A full issue of
@JHepatology dedicated to primary liver cancer ! https://www.journal-of-hepatology.eu/issue/S0168-8278(19)X0003-3 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Augusto Villanueva proslijedio/la je Tweet
Heterogeneity of liver cancer cells helps explain tumor progression in patients https://medicalxpress.com/news/2020-01-heterogeneity-liver-cancer-cells-tumor.html … via
@medical_xpressHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Augusto Villanueva proslijedio/la je Tweet
Very interesting work on intra tumoral heterogeneity (ITH) in liver cancer! Multiregional omics data from 71 samples (N = 14 patients) shows ITH in 30–40% of treatment-naive
#HCC They see different clonal expansion of adaptive immune system in distant regions of the same tumorhttps://twitter.com/augustoNYC/status/1217408520573849600 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our paper mapping intra-tumoral HCC heterogeneity, transcriptomic dynamics and clinical impact using
#immunogenomics out in@NatureComms. Great job#BojanLosic and@craig_mandy, awesome collab with@SergioLira100 and@IBMWatson.@TischCancerhttps://www.nature.com/articles/s41467-019-14050-z …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.